Metraipolis › archive › dc_968aba908b17

Trends and Characteristics of New Drug Approvals in China, 2011-2021 — Europe PMC PMID:36322325

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36322325
DOI
10.1007/s43441-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-07T17:57:17.355Z
SHA-256 of the archived text
e4e6c6b683eac84228e68e129bdd23dcf6727e3817882668a65371765fe67418
Stable URL of this page
https://metraipolis.com/documento/dc_968aba908b17

How to cite

Trends and Characteristics of New Drug Approvals in China, 2011-2021 — Europe PMC PMID:36322325 — Europe PMC (en), https://europepmc.org/article/MED/36322325 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_968aba908b17 (Metraipolis archive dc_968aba908b17, sha256 e4e6c6b683eac84228e68e129bdd23dcf6727e3817882668a65371765fe67418)
BibTeX
@misc{dc968aba908b17,
  title = {Trends and Characteristics of New Drug Approvals in China, 2011-2021 — Europe PMC PMID:36322325},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36322325},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_968aba908b17; sha256 e4e6c6b683eac84228e68e129bdd23dcf6727e3817882668a65371765fe67418},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36322325. Agents can read the archived copy with the MCP tool read_document.